Iron supplementation

"Iron supplementation" refers broadly to the medical practice of administering exogenous sources of elemental iron—most commonly via oral tablets/capsules containing ferrous salts such as ferrous sulfate or intravenous infusions containing ferric complexes—to correct states of deficiency or increased need. This approach aims primarily at restoring normal erythropoiesis by supplying sufficient substrate for hemoglobin synthesis within developing red blood cells. The process relies on physiological absorption pathways when given orally but bypasses them entirely when delivered parenterally. While highly effective at treating/preventing anemia caused by insufficient dietary intake/blood loss/malabsorption/increased requirements, inappropriate dosing can result in significant toxicity due to unbound circulating plasma free iron causing oxidative tissue injury ("iron poisoning")[1][5][6]. "Iron supplementation," therefore, describes an important clinical intervention—not a discrete molecular drug target—and should not be catalogued alongside receptors/enzymes/proteins unless referring specifically to one component compound/formulation thereof.

Other names

Iron therapyIron replacement therapyOral/parenteral iron treatment

The mechanism involves providing bioavailable elemental iron that can be absorbed and incorporated into hemoglobin during erythropoiesis. Oral preparations use intestinal transporters such as divalent metal transporter 1 (DMT1) and heme carrier protein 1 (HCP1)[1]. Parenteral preparations bypass gut absorption and deliver directly into circulation where they become part of the endogenous pool used by bone marrow cells for red blood cell production[5]. Iron’s physiological actions include supporting oxygen transport via hemoglobin/myoglobin synthesis; acting as cofactor in enzymes involved in energy metabolism/DNA synthesis/cell growth; supporting immune function; among others[2][4].